|
Martha Stewart exits Manhattan federal court after meeting with a probation officer March 8, 2004, in New York. (AP Photo/ Louis Lanzano)
|
INDEPTH: MARTHA STEWART
Timeline
CBC News Online | Jan. 6, 2006
Jan. 6, 2006
A federal appeals court in New York upholds the conviction of Martha Stewart. She had launched an appeal to try to clear her name.
March 4, 2005
Martha Stewart is released from prison shortly after midnight. She boards a private jet with her daughter for the trip to her New York estate. She will spend the next five months under house arrest, but is allowed to leave her home for 48 hours a week to go to work. On her web site, she tells her fans "experience of the past five months ... has been life altering and life affirming."
Oct. 8, 2004
Martha Stewart reports to the minimum-security federal prison in Alderson, West Virginia to begin serving her five-month sentence. Stewart says she will miss her pets during her stay in prison, but hopes to be free in time for spring gardening. She is scheduled to be released in March 2005.
A courtroom sketch shows Martha Stewart, second from right, sitting with her attorney Robert Morvillo, left, and her former broker Peter Bacanovic, center left, as they face Judge Miriam Goldman Cedarbaum at the United States Court House in New York Tuesday, Jan. 20, 2004.(AP Photo/Jane Rosenberg)
|
Sept. 15, 2004
Stewart says she wants to begin serving her five-month prison sentence as soon as possible "to put this nightmare behind me, both personally and professionally."
July 16, 2004
Martha Stewart is sentenced to five months in prison, five months home confinement and two years probation. Before the judge pronounced her sentence, Stewart said "Remember all the good I have done." The judge released Stewart while her lawyers prepare an appeal.
July 8, 2004
A U.S. federal judge denies Martha Stewart's request for a new trial based on allegations that government ink expert Larry Stewart lied in testimony at her first trial.
May 21, 2004
A prosecution witness in the Martha Stewart trial is charged with perjury in connection with his testimony. Larry Stewart – an ink expert – testified that a notation on a worksheet of Martha Stewart's investments about ImClone was made in a different kind of ink from other notes. The worksheet was a key piece of evidence for the prosecution in Martha Stewart's trial.
May 7, 2004
Martha Stewart Living Omnimedia reports a first-quarter loss of $20.3 million. The company cites a decline in advertising revenues and the impact of its founder and former chief executive Martha Stewart's criminal conviction for the worse-than-expected results. The company also hints it will change the name of its flagship magazine from Martha Stewart Living to Living.
May 5, 2004
A judge denies Martha Stewart's request for a new trial. She asked for a retrial after claiming that a juror lied about his arrest record in her original trial.
March 15, 2004
Martha Stewart quits as a director and chief creative officer of Martha Stewart Living Omnimedia, but she says she will take on the new position of "founding editorial director." Her resignation from the board comes after she was convicted of stock trading improprieties.
March 5, 2004
After three days of jury deliberations, Martha Stewart is convicted on one charge of conspiracy, one charge of obstruction of justice and two charges of making false statements to investigators.
Feb. 27, 2004
A judge drops one count of securities fraud that Martha Stewart was facing. It brings to four the number of charges on which she would be tried. It was the most serious charge she was facing.
Feb. 25, 2004
Stewart's defence team rests after calling just one witness. Steven Pearl testified for 45 minutes about notes he took at a meeting between Stewart and investigators two years earlier. Prosecutors said Stewart misled investigators by saying she didn't recall if her stockbroker called her the same day she sold her shares of ImClone. Pearl, a lawyer, said his notes showed that Stewart may have actually said that she didn't recall what time Peter Bacanovic called.
Feb. 13, 2004
Erbitux, the anti-cancer drug at the centre of the insider trading allegations against Martha Stewart receives regulatory approval. The drug was developed by ImClone Systems. Stewart was accused of selling shares in the company two years earlier, after receiving an illegal tip that the drug would not be approved because tests were not up to scratch. She had argued the stock was sold because she had a pre-existing agreement with her broker to sell the shares if the price went below $60.
Stewart enters Manhattan federal court, Wednesday, Feb. 4, 2004, in New York. (AP Photo/ Louis Lanzano)
|
|
Jan. 20, 2004
Martha Stewart enters pleas of "not guilty" to five counts relating to her sale of almost 4,000 shares of ImClone Systems stock on Dec. 27, 2001. That was just one day before U.S. health regulators released a report on the drug that sent the stock diving. Stewart avoided a loss of $51,000 US by selling the shares when she did.
Jan. 6, 2004
Jury selection begins in Martha Stewart's trial, with potential jurors being told to fill out questionnaires.
Dec. 4, 2003
Martha Stewart steps down as chair and chief executive officer of Martha Stewart Living Omnimedia Inc. – but stays on as a member of the board.
June 10, 2003
ImClone founder Sam Waksal is sentenced to seven years in prison and fined $4 million on charges of insider trading.
June 4, 2003
A U.S. federal grand jury in Manhattan indicts Martha Stewart on nine counts involving insider trading. Stewart is accused of dumping 4,000 shares of ImClone Inc. after receiving an illegal tip that a cancer drug the company was testing was not going to be approved. The sale saves her $51,000 US.
Oct. 15, 2002
ImClone founder Sam Waksal pleads guilty to six charges of bank fraud and conspiracy in the insider trading scandal involving Martha Stewart. He had been accused of leaking confidential information to friends and relatives that the company's Erbitux cancer drug had been rejected by U.S. regulators.
Oct. 2, 2002
An aide to Martha Stewart's broker admits he withheld information from the U.S. Securities and Exchange Commission and the FBI while federal investigators probed whether Stewart sold about 4,000 shares of ImClone Systems using inside information.
He said he received extra vacation time and a free airline ticket in exchange for keeping silent on the insider tip to Stewart.
Aug. 8, 2002
A federal grand jury indicts former ImClone CEO Sam Waksal on nine counts of insider trading.
June 12, 2002
Former ImClone CEO Sam Waksal is arrested at his home and charged with insider trading. Waksal is accused of tipping relatives and friends that ImClone's application to market anti-cancer drug Erbitux was going to be rejected by the U.S. Food and Drug Administration. Among the friends said to have been tipped was Martha Stewart.
Dec. 28, 2001
The U.S. Food and Drug Administration issues a negative report on the anti-cancer drug Erbitux, citing inadequate testing procedures. The company's share prices plunge.
Dec. 27, 2001
Martha Stewart sells 4,000 shares of ImClone Inc. She says she had an agreement with her broker to sell if the share price dropped to $60. Relatives of the company's CEO, Sam Waksal, sold their shares in the company on the same day. The Securities Exchange Commission later said Waksal tried to sell millions of dollars worth of his own shares, but two brokerages refused to process the order.
^TOP
|
|
 |
 RELATED STORIES: |
Court upholds Martha Stewart's conviction (Jan. 6, 2005)
Martha Stewart's 'Apprentice' cancelled (Nov. 14, 2005)
Martha Stewart to get satellite radio channel (April 18, 2005)
Martha Stewart out of prison (March 4, 2005)
Martha Stewart reports to prison (Oct. 8, 2004)
Martha Stewart handed five month prison sentence (July 16, 2004)
Martha Stewart's request for new trial denied (July 8, 2004)
Martha Stewart quits board of her company (March 15, 2004)
Martha Stewart found guilty of all charges; vows to appeal (March 5, 2004)
Martha Stewart trial gets underway (Jan. 20, 2004)
Martha Stewart under criminal investigation (Dec. 4, 2003)
|
|
| MORE: |
|
|
|
